Apexigen, Inc.

Symbol: APGN

NASDAQ

0.3851

USD

Market price today

  • -0.3572

    P/E Ratio

  • -0.0036

    PEG Ratio

  • 9.57M

    MRK Cap

  • 0.00%

    DIV Yield

Apexigen, Inc. (APGN) Financial Statements

On the chart you can see the default numbers in dynamics for Apexigen, Inc. (APGN). Companys revenue shows the average of 0 M which is 0.000 % gowth. The average gross profit for the whole period is 0 M which is 0.000 %. The average gross profit ratio is 0.000 %. The net income growth for the company last year performance is 0.089 % which equals -0.102 % % on average for the whole company history.,

Balance Sheet

Diving into the fiscal trajectory of Apexigen, Inc., we observe an average asset growth. This rate, interestingly, stands at , reflecting both the company's highs and lows. When compared quarter-over-quarter, this figure adjusts to 0. A look back at the past year reveals a total asset change of -0.415. In the realm of current assets, APGN clocks in at 21.193 in the reporting currency. A significant portion of these assets, precisely 16.799, is held in cash and short-term investments. This segment shows a change of -0.538% when juxtaposed with last year's data. Long-term investments of the company, while not its focus, stand at 0, if any, in the reporting currency. This indicates a difference of -100.000% from the last reporting period, reflecting the company's strategic shifts. The debt profile of the company shows a total long-term debt of 0 in the reporting currency. This figure signifies a year_over_year change of -0.792%. Shareholder value, as depicted by the total shareholder equity, is valued at 6.377 in the reporting currency. The year over year change in this aspect is -1.047%. A deeper dive into the company's financials reveals additional details. The net receivables are valued at 0, with an inventory valuation of 0, and goodwill valued at 0, if any. The total intangible assets, if present, are valued at 0.

common:word.in-mln

USD
Growth
TTM202220212020

balance-sheet.row.cash-and-short-term-investments

59.5716.836.460.5

balance-sheet.row.short-term-investments

9.96212.935.2

balance-sheet.row.net-receivables

0000

balance-sheet.row.inventory

0000

balance-sheet.row.other-current-assets

7.652.61.70.9

balance-sheet.row.total-current-assets

75.4221.23861.4

balance-sheet.row.property-plant-equipment-net

0.620.30.71.4

balance-sheet.row.goodwill

0000

balance-sheet.row.intangible-assets

0000

balance-sheet.row.goodwill-and-intangible-assets

0000

balance-sheet.row.long-term-investments

0058.10

balance-sheet.row.tax-assets

0000

balance-sheet.row.other-non-current-assets

5.051.4-57.80.1

balance-sheet.row.total-non-current-assets

5.671.71.11.5

balance-sheet.row.other-assets

0000

balance-sheet.row.total-assets

81.0922.939.162.8

balance-sheet.row.account-payables

14.875.34.53.5

balance-sheet.row.short-term-debt

0.320.10.40.6

balance-sheet.row.tax-payables

000.10

balance-sheet.row.long-term-debt-total

000.10.5

Deferred Revenue Non Current

0000

balance-sheet.row.deferred-tax-liabilities-non-current

0---

balance-sheet.row.other-current-liab

24.665.48.56.6

balance-sheet.row.total-non-current-liabilities

0.050158.8159.2

balance-sheet.row.other-liabilities

0000

balance-sheet.row.capital-lease-obligations

0.320.10.51.2

balance-sheet.row.total-liab

63.5116.5175.8171.9

balance-sheet.row.preferred-stock

0000

balance-sheet.row.common-stock

0.01000

balance-sheet.row.retained-earnings

-718.89-176.8-144.7-115.8

balance-sheet.row.accumulated-other-comprehensive-income-loss

-0.01000

balance-sheet.row.other-total-stockholders-equity

736.47183.286.8

balance-sheet.row.total-stockholders-equity

17.586.4-136.7-109

balance-sheet.row.total-liabilities-and-stockholders-equity

81.0922.939.162.8

balance-sheet.row.minority-interest

0000

balance-sheet.row.total-equity

17.586.4-136.7-109

balance-sheet.row.total-liabilities-and-total-equity

81.09---

Total Investments

9.96212.935.2

balance-sheet.row.total-debt

0.320.10.51.2

balance-sheet.row.net-debt

-49.29-14.7-22.9-24.1

Cash Flow Statement

The financial landscape of Apexigen, Inc. has seen a noteworthy change in free cash flow over the last period, exhibiting a shift of -0.284. The company recently extended its share capital by issuing 20.59, marking a difference of -93.548 compared to the previous year. Interestingly, a portion of the company's stock, specifically 0, was bought back by the company itself. This action resulted in a change of 0.000 from the previous year. Meanwhile, the company's account payables are currently standing at 0.32 in the reporting currency. The company's investing activities resulted in net cash usage, amounting to 10955000.000 in the reporting currency. This is a shift of -0.503 from the previous year. In the same period, the company recorded 0.11, 0, and 0, which are significant to understanding the company's investment and repayment strategies. The company's financing activities led to a net cash usage of 0.000, with a year over year difference of 0.000. Furthermore, the company allocated 0 for dividend payouts to its shareholders. At the same time, it engaged in other financial maneuvers, referred to as -9.5, which also significantly impacted its cash flow during this period. These components, taken together, paint a comprehensive picture of the company's financial status and strategic approach towards cash flow management.

common:word.in-mln

USD
Growth
TTM202220212020

cash-flows.row.net-income

4086.31-32.1-28.9-24.1

cash-flows.row.depreciation-and-amortization

0.10.10.10.1

cash-flows.row.deferred-income-tax

000.20.1

cash-flows.row.stock-based-compensation

2.31.91.11.3

cash-flows.row.change-in-working-capital

-3738.7-231.7

cash-flows.row.account-receivables

0000

cash-flows.row.inventory

0000

cash-flows.row.account-payables

-112.120.30.80.8

cash-flows.row.other-working-capital

-3626.58-2.32.20.9

cash-flows.row.other-non-cash-items

24.981.40.50.8

cash-flows.row.net-cash-provided-by-operating-activities

374.98000

cash-flows.row.investments-in-property-plant-an-equipment

-0.01-0.1-0.10

cash-flows.row.acquisitions-net

0058.10

cash-flows.row.purchases-of-investments

-10.01-18.9-20.2-67.3

cash-flows.row.sales-maturities-of-investments

-6923.553042.343.2

cash-flows.row.other-investing-activites

492.270-58.10

cash-flows.row.net-cash-used-for-investing-activites

-6441.31122-24.2

cash-flows.row.debt-repayment

0000

cash-flows.row.common-stock-issued

23.3920.600

cash-flows.row.common-stock-repurchased

0000

cash-flows.row.dividends-paid

0000

cash-flows.row.other-financing-activites

6169.3-9.5012.9

cash-flows.row.net-cash-used-provided-by-financing-activities

6192.6911.1012.9

cash-flows.row.effect-of-forex-changes-on-cash

-193.97000

cash-flows.row.net-change-in-cash

-67.6-8.6-1.8-31.2

cash-flows.row.cash-at-end-of-period

49.6114.823.425.3

cash-flows.row.cash-at-beginning-of-period

117.2123.425.356.5

cash-flows.row.operating-cash-flow

374.98-30.7-23.9-20

cash-flows.row.capital-expenditure

-0.01-0.1-0.10

cash-flows.row.free-cash-flow

374.97-30.8-24-20

Income Statement Row

Apexigen, Inc.'s revenue saw a change of 0.000% compared with the previous period. The gross profit of APGN is reported to be 0. The company's operating expenses are 32.69, showing a change of 12.878% from the last year. The expenses for depreciation and amortization are 0.11, which is a 0.048% change from the last accounting period. Operating expenses are reported to be 32.69, which shows a 12.878% year-over-year change. Selling and marketing expenses are 0, which is a 0.000% change compared to the previous year. The EBITDA based on the recent numbers is 0, representing a -0.129% year-over-year growth. The operating income is -32.69, which shows a 0.129% change when compared to the previous year. The change in the net income is 0.089%. The net income for the last year was -31.45.

common:word.in-mln

USD
Growth
TTM202220212020

income-statement-row.row.total-revenue

0000

income-statement-row.row.cost-of-revenue

0000

income-statement-row.row.gross-profit

0000

income-statement-row.row.gross-profit-ratio

0000

income-statement-row.row.research-development

14.61---

income-statement-row.row.selling-general-administrative

13.21---

income-statement-row.row.selling-and-marketing-expenses

0---

income-statement-row.row.other-expenses

0.80.600

income-statement-row.row.operating-expenses

27.8232.72924.5

income-statement-row.row.cost-and-expenses

27.8232.72924.5

income-statement-row.row.interest-income

-0.05000.4

income-statement-row.row.interest-expense

-7.68-0.600

income-statement-row.row.selling-and-marketing-expenses

0---

income-statement-row.row.total-other-income-expensenet

0.80.600.4

income-statement-row.row.ebitda-ratio-caps

0---

income-statement-row.row.other-operating-expenses

0.80.600

income-statement-row.row.total-operating-expenses

0.80.600.4

income-statement-row.row.interest-expense

-7.68-0.600

income-statement-row.row.depreciation-and-amortization

0.040.10.10.1

income-statement-row.row.ebitda-caps

-27.78---

income-statement-row.row.operating-income

-27.82-32.7-29-24.5

income-statement-row.row.income-before-tax

-27.02-32.1-28.9-24.1

income-statement-row.row.income-tax-expense

-0.36-0.60-0.4

income-statement-row.row.net-income

-26.66-31.5-28.9-23.7

Frequently Asked Question

What is Apexigen, Inc. (APGN) total assets?

Apexigen, Inc. (APGN) total assets is 22855000.000.

What is enterprise annual revenue?

The annual revenue is N/A.

What is firm profit margin?

Firm profit margin is 0.000.

What is company free cash flow?

The free cash flow is 15.165.

What is enterprise net profit margin?

The net profit margin is 0.000.

What is firm total revenue?

The total revenue is 0.000.

What is Apexigen, Inc. (APGN) net profit (net income)?

The net profit (net income) is -31452000.000.

What is firm total debt?

The total debt is 106000.000.

What is operating expences number?

The operating expences are 32686000.000.

What is company cash figure?

Enretprise cash is 9369000.000.